Commonest Overgrowth Syndromes

REFERENCES

• Neri G, Moscarda M. Overgrowth syndromes: a classification. Endocr Dev 14:53–60, 2009.
   PubMedGoogle Scholar
• Cohen MM Jr, Neri G, Weksberg R Overgrowth Syndromes. Oxford: Oxford University Press, pp. 1–10, 2002.
   Google Scholar
• Visser R, Kant SG, Wit JM, Breuning MH. Overgrowth syndromes: from classical to new. Pediatr Endocrinol Rev 6:375–94, 2009.
   Google Scholar
• Vora N, Bianchi DW. Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn 29:923–9, 2009.
   Google Scholar
• Carty MJ, Taghinia A, Upton J. Overgrowth conditions: a diagnostic and therapeutic conundrum. Hand Clin 25:229–45, 2009.
   Google Scholar
• Beckwith JB. Extreme cytomegaly of the adrenal fetal cortex, omphalocele, hyperplasia of kidneys and pancreas, and Leydig-cell hyperplasia: Another syndrome? Western Society for Pediatric Research: Abstract, 1963.
   Google Scholar
• Wiedemann HR. Complexe malformatif familial avec hernie ombilicale et macroglossia, un ‘syndrome nouveau. J Genet Hum 13:223–32, 1964.
   PubMedGoogle Scholar
• Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet 18:8–14, 2010.
   PubMed Web of Science ®Google Scholar
• Spivey PS, Bradshaw WT. Recognition and management of the infant with Beckwith-Wiedemann Syndrome. Adv Neonatal Care 9:279–84; quiz 285, 2009.
   Google Scholar
• Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, Bowdin SC, Riccio A, Sebastio G, Bliek J, Schofield PN, Reik W, Macdonald F, Maher ER. Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndrome. Eur J Hum Genet 13:1025–32, 2005.
   PubMed Web of Science ®Google Scholar
• Weksberg R, Shuman C, Smith AC. Beckwith–Wiedemann Syndrome. Am J Med Genet 137:12–23, 2005.
   Google Scholar
• Enklaar T, Zabel BU, Prawitt D. Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 8:1–19, 2006.
   Google Scholar
• Bliek J, Verde G, Callaway J, Maas SM, De Crescenzo A, Sparago A, Cerrato F, Russo S, Ferraiuolo S, Rinaldi MM, Fischetto R, Lalatta F, Giordano L, Ferrari P, Cubellis MV, Larizza L, Temple IK, Mannens MM, Mackay DJ, Riccio A. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. Eur J Hum Genet 17:611–9, 2009.
   PubMed Web of Science ®Google Scholar
• Dalal AB, Phadke SR, Pradhan M, Sharda S. Hemihyperplasia syndromes. Indian J Pediatr 73:609–15, 2006.
   Google Scholar
• Stoll C, Alembik Y, Steib JP, De Saint-Martin A. Twelve cases with hemihypertrophy: etiology and follow up. Genet Couns 4:119–26, 1993.
   Google Scholar
• Cohen MM Jr, Neri G, Weksberg R. Hemihyperplasia (hypertrophy). In: Overgrowth Syndromes. Oxford: Oxford University Press, pp. 32–7, 2002.
   Google Scholar
• Bliek J, Maas S, Alders M, Merks JH, Mannens M. Epigenotype, phenotype, and tumors in patients with isolated hemihyperplasia. J Pediatr 153:95–100, 2008.
   Google Scholar
• Shuman C, Smith AC, Steele L, Ray PN, Clericuzio C, Zackai E, Parisi MA, Meadows AT, Kelly T, Tichauer D, Squire JA, Sadowski P, Weksberg R. Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies. Am J Med Genet A 140:1497–1503, 2006.
   PubMedGoogle Scholar
• Martin RA, Grange DK, Zehnbauer B, Debaun MR. LIT1 and H19 methylation defects in isolated hemihyperplasia. Am J Med Genet A 134A:129–31, 2005.
   Google Scholar
• Clericuzio CL, Martin RA. Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med 11:220–2, 2009.
   Google Scholar
• Zarate YA, Mena R, Martin LJ, Steele P, Tinkle BT, Hopkin RJ. Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol. Am J Med Genet A 149A:1691–7, 2009.
   Google Scholar
• Simpson JL, Landey S, New M, German J. A previously unrecognized X-linked syndrome of dysmorphia. Birth Defects 11:18–24, 1975.
   PubMedGoogle Scholar
• Golabi M, Rosen L. A new X-linked mental retardation-overgrowth syndrome. Am J Med Genet 17:345–58, 1984.
   Google Scholar
• Behmel A, Plochl E, Rosenkranz W. A new X-linked dysplasia gigantism syndrome: Identical with the Simpson dysplasia syndrome? Hum Genet 67:409–13, 1984.
   Google Scholar
• Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet 9:1321–8, 2000.
   Google Scholar
• Davoodi J, Kelly J, Gendron NH, MacKenzie AE. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics 7:2300–10, 2007.
   PubMed Web of Science ®Google Scholar
• Sakazume S, Okamoto N, Yamamoto T, Kurosawa K, Numabe H, Ohashi Y, Kako Y, Nagai T, Ohashi H. GPC3 mutations in seven patients with Simpson-Golabi-Behmel syndrome. Am J Med Genet A 143A:1703–7, 2007.
   Google Scholar
• James A, Culver K, Golabi M. Simpson-Golabi-Behmel Syndrome. In: Gene Reviews [Internet], Pagon RA, Bird TC, Dolan CR, Stephens K, eds. Seattle, WA: University of Washington, 1993.
   Google Scholar
• Alessandri JL, Cuillier F, Ramful D, Ernould S, Robin S, de Napoli-Cocci S, Rivière JP, Rossignol S. Perlman syndrome: report, prenatal findings and review. Am J Med Genet A 146A:2532–7, 2008.
   Google Scholar
• Perlman M, Goldberg GM, Bar-Ziv J, Danovitch G. Renal hamartomas and nephroblastomatosis with fetal gigantism: A familial syndrome. J Pediatr 83:414–8, 1973.
   PubMed Web of Science ®Google Scholar
• Perlman M, Levin M, Witels B. Syndrome of fetal gigantism,renal hamartomas and nephroblastomatosis with Wilms’ tumor. Cancer 35:1212–7, 1975.
   PubMedGoogle Scholar
• Liban E, Kozenitzky IL. Metanephric hamartomas and nephroblastomatosis in siblings. Cancer 25:885–8, 1970.
   Google Scholar
• Coppin B, Moore I, Hatchwell E. Extending the overlap of three congenital overgrowth syndromes. Clin Genet 51:375–8, 1997.
   Google Scholar
• Sotos JF, Dodge PR, Muirhead D, Crawford JD, Talbot NB. Cerebral gigantism in childhood: A syndrome of excessively rapid growth with acromelic features and a non-progressive neurologic disorder. N Engl J Med 272:109–16, 1964.
   Google Scholar
• Baujat G, Cormier-Daire V. Sotos syndrome. Orphanet J Rare Dis 2:36, 2007.
   PubMedGoogle Scholar
• Cole TRP, Hughes HE. Sotos syndrome: a study of the diagnostic criteria and natural history. J Med Genet 31:20–32, 1994.
   PubMed Web of Science ®Google Scholar
• Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 72:132–43, 2003.
   PubMed Web of Science ®Google Scholar
• Rio M, Clech L, Amiel J, Faivre L, Lyonnet S, Le Merrer M, Odent S, Lacombe D, Edery P, Brauner R, Raoul O, Gosset P, Prieur M, Vekemans M, Munnich A, Colleaux L, Cormier-Daire V. Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet 40:436–40, 2003.
   Google Scholar
• Kurotaki N, Harada N, Shimokawa O, Miyake N, Kawame H, Uetake K, Makita Y, Kondoh T, Ogata T, Hasegawa T, Nagai T, Ozaki T, Touyama M, Shenhav R, Ohashi H, Medne L, Shiihara T, Ohtsu S, Kato Z, Okamoto N, Nishimoto J, Lev D, Miyoshi Y, Ishikiriyama S, Sonoda T, Sakazume S, Fukushima Y, Kurosawa K, Cheng JF, Yoshiura K, Ohta T, Kishino T, Niikawa N, Matsumoto N. Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats possibly mediate the common deletion. Hum Mutat 22:378–87, 2003.
   Google Scholar
• Fagali C, Kok F, Nicola P, Kim C, Bertola D, Albano L, Koiffmann CP. MLPA analysis in 30 Sotos syndrome patients revealed one total NSD1 deletion and two partial deletions not previously reported. Eur J Med Genet 52:333–6, 2009..
   Google Scholar
• Visser R, Gijsbers A, Ruivenkamp C, Karperien M, Reeser HM, Breuning MH, Kant SG, Wit JM. Genome-wide SNP array analysis in patients with features of sotos syndrome. Horm Res Paediatr 73:265–74, 2010.
   Google Scholar
• Fryssira H, Drossatou P, Sklavou R, Barambouti F, Manolaki N. Two cases of Sotos syndrome with novel mutations of the NSD1 gene. Genet Couns 21:53–9, 2010.
   Google Scholar
• Zechner U, Kohlschmidt N, Kempf O, Gebauer K, Haug K, Engels H, Haaf T, Bartsch O. Familial Sotos syndrome caused by a novel missense mutation, C2175S, in NSD1 and associated with normal intelligence, insulin dependent diabetes, bronchial asthma, and lipedema. Eur J Med Genet 52:306–10, 2009.
   Google Scholar
• Schrander-Stumpel CT, Fryns JP, Hamers GG. Sotos syndrome and de novo balanced autosomal translocation (t(3;6)(p21;p21)). Clin Genet 37:226–9, 1990.
   Google Scholar
• Wajntal A, Moretti-Ferreira D, De Souza DH, Koiffmann CP. Cytogenetic evidence of involvement of chromosome regions 15q12 and 12q15 in conditions with associated overgrowth. DNA Cell Biol 12;227–31, 1993.
   Google Scholar
• Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet 15:264–71, 2007.
   PubMed Web of Science ®Google Scholar
• Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, Das S, Horn D, Hughes HE, Temple IK, Faravelli F, Waggoner D, Turkmen S, Cormier-Daire V, Irrthum A, Rahman N; Childhood Overgrowth Collaboration. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77:193–204, 2005.
   PubMedGoogle Scholar
• Opitz JM, Weaver DW, Reynolds JF. The syndromes of Sotos andWeaver: reports and review. Am J Med Genet 79:294–304, 1998.
   PubMedGoogle Scholar
• Weaver DD, Graham CB, Thomas IT, Smith DW. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr 84:547–52, 1974.
   PubMed Web of Science ®Google Scholar
• Proud VK, Braddock SR, Cook L, Weaver DD. Weaver syndrome: Autosomal dominant inheritance of the disorder. Am J Med Genet 79:305–10, 1998.
   Google Scholar
• Cohen MM Jr, Neri G, Weksberg R. Weaver syndrome. In: Overgrowth Syndromes. Oxford: Oxford University Press, pp 59–65, 2002.
   Google Scholar
• Cohen MM Jr. Bannayan-Riley-Ruvalcaba syndrome. Renaming a condition previously thought to represent three separate entities. Am J Med Genet 35:291, 1990.
   Google Scholar
• Gorlin RJ, Cohen MM Jr, Condon LM, Burke BA. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44:307–14, 1992.
   PubMedGoogle Scholar
• Erkek E, Hizel S, Sanlý C, Erkek AB, Tombakoglu M, Bozdogan O, Ulkatan S, Akarsu C. Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome. J Am Acad Dermatol 53:639–43, 2005.
   PubMed Web of Science ®Google Scholar
• Bannayan GA. Lipomatosis, angiomatosis and.macroencephaly: A previously undescribed congenital syndrome. Arch Pathol 92:1–5, 1971.
   PubMedGoogle Scholar
• Riley HD, Smith WR. Macrocephaly, pseudopapilledema and multiple hemangiomata. Pediatrics 26:293–300, 1960.
   Google Scholar
• Ruvalcaba RHA, Myhre S, Smith DW. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet 18:413–6, 1980.
   Google Scholar
• Dvir M, Beer S, Aladjem M. Heredofamilial syndrome of mesodermal hamartomas, macrocephaly and pseudopapilledema. Pediatrics 81:287–90, 1988.
   Google Scholar
• Eng C. PTEN: one gene, many syndromes. Hum Mutat 22:183–98, 2003.
   PubMed Web of Science ®Google Scholar
• Weng LP, Smith WM, Brown JL, Eng C. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet 10:605–16, 2001.
   PubMed Web of Science ®Google Scholar
• Weng L, Brown J, Eng C. TEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10:237–42, 2001.
   PubMed Web of Science ®Google Scholar
• Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C, Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7:507–17, 1998.
   PubMed Web of Science ®Google Scholar
• Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM Jr, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C, PTEN mutation spectrum and genotype- phenotype correlations in Bannayan-Riley- Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461–72, 1999.
   PubMed Web of Science ®Google Scholar
• Arch EM, Goodman BK, Van Wesep RA. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 71:489–93, 1997.
   Google Scholar
• Sarquis MS, Agrawal S, Shen L, Pilarski R, Zhou XP, Eng C. Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet 79:23–30, 2006.
   Google Scholar
• Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 44:579–85, 2007.
   Google Scholar
• Pezzolesi MG, Li Y, Zhou XP, Pilarski R, Shen L, Eng C. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Am J Hum Genet 79:923–34, 2006.
   Google Scholar
• Lynch NE, Lynch SA, McMenamin J, Webb D. Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay. Arch Dis Child 94:553–4, 2009.
   Google Scholar
• Cohen MM Jr, Hayden PW. A newly recognized hamartomatous syndrome. Birth Defects 15:291–6, 1979.
   PubMedGoogle Scholar
• Wiedemann H-R, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. The Proteus syndrome, partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly, skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr 140:5–12, 1983.
   PubMed Web of Science ®Google Scholar
• Samlaska CP, Levin SW, James WD, Benson PM, Walker JC, Perlik PC. Proteus syndrome. Arch Dermatol 125:1109–14, 1989.
   PubMedGoogle Scholar
• Happle R, Steijlen PM, Theile U, Karitzky D, Tinschert S, Albrecht-Nebe H, Küster W. Patchy dermal hypoplasia as a characteristic feature of Proteus syndrome. Arch Dermotol 133:77–80, 1997.
   Google Scholar
• Gehlen JM, van Gemert WG, de Haan MW, Baeten CG. Severe anal bleeding in Proteus syndrome: a case report. Tech Coloproctol 11:158–60, 2007.
   Google Scholar
• Biesecker L. The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet 14:1151–7, 2006.
   PubMed Web of Science ®Google Scholar
• Pazzaglia UE, Beluffi G, Bonaspetti G, Ranchetti F. Bone malformations in Proteus syndrome: an analysis of bone structural changes and their evolution during growth. Pediatr Radiol 37:829–35, 2007.
   PubMed Web of Science ®Google Scholar
• De Silva MH, Jayantha UK, Hapuarachchi GK, Hewawitharana GP. A case of Proteus syndrome (elephant man). Ceylon Med J 51:38, 2006.
   Google Scholar
• Zhou X, Hampel H, Thiele H, Gorlin RJ, Hennekam RC, Parisi M, Winter RM, Eng C. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358:210–11, 2001.
   PubMed Web of Science ®Google Scholar
• Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 16:899–906, 1987.
   PubMed Web of Science ®Google Scholar
• Biesecker LG, Peters KF, Darling TN, Choyke P, Hill S, Schimke N, Cunningham M, Meltzer P, Cohen MM Jr. Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a form of hemihyperplasia. Am J Med Genet 79:311–318, 1998.
   Google Scholar
• Biesecker LG, Happle R, Mulliken JB, Weksberg R, Graham JM Jr, Viljoen DL, Cohen MM Jr. Proteus syndrome:diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet 84:389–95, 1999.
   PubMed Web of Science ®Google Scholar
• Cohen MM Jr, Neri G, Weksberg R. Klippel-Trenaunay syndrome. In: Overgrowth Syndromes, Oxford: Oxford University Press, pp. 111–24, 2002.
   Google Scholar
• Klippel M, Trenaunay P. Du naevus variqueux osteohypertrophique. Arch Genet Med Paris 3:611–72, 1990.
   Google Scholar
• Parkes Weber F. Angioma formation in connection with hypertrophy of limbs and hemihypertrophy. Br J Dermatol 19:231, 1907.
   Google Scholar
• Parkes Weber F. Haemangiectatic hypertrophies of the foot and lower extremity. London: Med Press, 136:261, 1908.
   Google Scholar
• Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal JM, Dallapiccola B, Fischer G, Frieden IJ, Garzon M, Harper J, Johnson-Patel J, Labrèze C, Martorell L, Paltiel HJ, Pohl A, Prendiville J, Quere I, Siegel DH, Valente EM, Van Hagen A, Van Hest L, Vaux KK, Vicente A, Weibel L, Chitayat D, Vikkula M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 29:59–965, 2008.
   Google Scholar
• Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73:1240–9, 2003.
   PubMed Web of Science ®Google Scholar
• Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCorleto PE, Driscoll DJ, Borrow J, Wang Q. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel–Trenaunay syndrome. Nature 427:640–5, 2004.
   PubMed Web of Science ®Google Scholar
• Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current management. Phlebology 22:291–8, 2007.
   PubMed Web of Science ®Google Scholar
• Di Rocco C, Tamburrini G. Sturge-Weber syndrome. Childs Nerv Syst 22:909–21, 2006.
   PubMedGoogle Scholar
• Schrimer R. Ein fall von telangiektasie. Albrecht von Graefes. Arch Ophtalmol 7:119–21, 1860.
   Google Scholar
• Sturge WA. A case of partial epilepsy apparently due to a lesion of the vasomotor centers of the brain. Trans Clin Soc Lond 12:162–7, 1879.
   Google Scholar
• Weber FP. Right-sided hemi-hypertrophy resulting from right sided congenital spastic hemiplegia. J Neurol Psychopathol 3:134–9, 1922.
   PubMedGoogle Scholar
• Comi A. Pathophysiology of Sturge–Weber syndrome. J Child Neurol 18:509–16, 2003.
   PubMed Web of Science ®Google Scholar
• Roach ES. Neurocutaneous syndromes. Pediatr Clin North Am 39:591–620, 1992.
   PubMed Web of Science ®Google Scholar
• Maffucci A. Di un caso di encondroma ed angioma multiple. Contribuzione alia genesi embrionale dei tumor. Mov Med Chir 3:399–412, 565–75, 1881.
   Google Scholar
• Williams DS. Maffucci's syndrome. J Insur Med 40:146–7, 2008.
   Google Scholar
• Lissa FC, Argente JS, Antunes GN, Basso Fde O, Furtado J. Maffucci syndrome and soft tissue sarcoma: a case report. Int Semin Surg Oncol 6:2, 2009.
   Google Scholar
• Biber C, Ergun P, Turay UY, Erdogan Y, Hizel SB. A case of Maffucci's Syndrome with pleural effusion: ten-year follow-up. Ann Acad Med Singapore 33:347–50, 2004.
   Google Scholar
• Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations.Part II: associated syndromes. J Am Acad Dermatol 56:541–64, 2007.
   PubMedGoogle Scholar
• Lewis RJ, Ketcham AS. Maffucci's Syndrome: Functional and neoplastic sigficance –case report and review of the literature. J Bone Joint Surg Am 55:1465–79, 1973.
   Web of Science ®Google Scholar
• Ferner RE. The neurofibromatoses. Pract Neurol 10:82–9, 2010.
   PubMedGoogle Scholar
• Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Neurofibromatosis type 2. Lancet 373:1974–86, 2009.
   PubMed Web of Science ®Google Scholar
• Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 61:1–14; quiz 15–6, 2009.
   PubMed Web of Science ®Google Scholar
• Mercaldo V, Descalzi G, Zhuo M. Fragile X mental retardation protein in learning-related synaptic plasticity. Mol Cells 28:501–7, 2009.
   PubMed Web of Science ®Google Scholar
• Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: a family of disorders. Adv Pediatr 56:165–86, 2009.
   Google Scholar